Lee Danner & Bass Inc. Acquires New Position in Roche Holding AG (OTCMKTS:RHHBY)

Lee Danner & Bass Inc. acquired a new stake in Roche Holding AG (OTCMKTS:RHHBY) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 9,435 shares of the company’s stock, valued at approximately $327,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AlphaMark Advisors LLC bought a new position in shares of Roche during the first quarter valued at approximately $34,000. First Horizon Advisors Inc. grew its holdings in shares of Roche by 19.8% during the fourth quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock valued at $75,000 after purchasing an additional 342 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Roche by 61.5% during the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock valued at $175,000 after purchasing an additional 1,919 shares during the last quarter. Forte Capital LLC ADV bought a new position in shares of Roche during the fourth quarter valued at approximately $323,000. Finally, HighPoint Advisor Group LLC bought a new position in shares of Roche during the fourth quarter valued at approximately $373,000.

Analysts Set New Price Targets

RHHBY has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft upgraded Roche from a “sell” rating to a “hold” rating in a research report on Friday, May 17th. The Goldman Sachs Group initiated coverage on Roche in a research report on Thursday, May 30th. They set a “sell” rating for the company. Two research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $40.00.

Roche Price Performance

RHHBY opened at $42.33 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.35 and a quick ratio of 1.04. The business has a fifty day simple moving average of $38.40 and a 200-day simple moving average of $34.23. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $42.43.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.